JOE
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 13 October 2008

Journal of Endocrinology 2009;200:85.

Journal of Endocrinology (2008) In press
DOI: 10.1677/JOE-08-0134
© 2008 Society for Endocrinology
This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JOE-08-0134v1
200/1/85    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rotinen, M.
Right arrow Articles by Villar, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rotinen, M.
Right arrow Articles by Villar, J.

RESEARCH

Estradiol induces type 8 17β-Hydroxysteroid Dehydrogenase expression: crosstalk between estrogen receptor alpha and C/EBPβ.

Mirja Rotinen, Jon Celay, Marta Alonso, Arantxa Arrazola, Ignacio Encio and Joaquin Villar

M Rotinen, Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain
J Celay, Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain
M Alonso, Neuro-oncology, MD anderson Cancer Center, Houston, United States
A Arrazola, Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain
I Encio, Department of Health Sciences, Universidad Publica de Navarra, Pamplona, Spain
J Villar, Radiation Medicine, Georgetown University, Washington, 20057-1482, United States

Correspondence: Joaquin Villar, Email: villarj{at}mail.nih.gov

Abstract

17β-hydroxysteroid dehydrogenases (17β-HSD) are the enzymes responsible for the reversible interconversion of 17-hydroxy and 17-keto steroids. The human and mouse type 8 17β-HSD (17β-HSD8) selectively catalyze the conversion of estradiol (E2) to estrone (E1). We previously described that 17β-HSD8 is transcriptionally regulated by C/EBPβ, and that C/EBPβ is bound to CCAAT boxes located at -5 and -46 of the transcription start site in basal conditions in HepG2 cells. Furthermore, ectopic expression of C/EBPβ transactivated the 17β-HSD8 promoter activity. Here, we show that 17β-HSD8 expression is up-regulated in response to E2 in the Estrogen Receptor alpha (ER{alpha}) positive MCF-7 cells. Results showed that this induction is mediated by ER{alpha} because (i) E2 did not induced 17β-HSD8 expression in ER{alpha} negative HepG2 cells,(ii) ectopic expression of ER{alpha} restored E2-induced 17β-HSD8 expression, and (iii) this induction was blocked by the anti-estrogen receptor ICI 182,780. Additional experiments showed that no estrogen response element (ERE) was necessary for this regulation. However, the CCAAT boxes located at the 17β-HSD8 proximal promoter were required for E2-induced transcription. Furthermore, co-immunoprecipitation studies revealed tethering of ER{alpha} to C/EBPβ in response to E2 in cells expressing ER{alpha}. Additionally, chromatin immunoprecipitation assays demonstrated that, in response to E2, ER{alpha} is recruited to the CCAAT boxes in which C/EBPβ is already bound. Taken together, our results reveal that ER{alpha} is involved in the transcriptional regulation of 17β-HSD8 gene in response to E2 through its interaction with C/EBPβ.







HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.